Metallo-β-lactamases in the age of multidrug resistance: from structure and mechanism to evolution, dissemination, and inhibitor design

G Bahr, LJ Gonzalez, AJ Vila - Chemical reviews, 2021 - ACS Publications
Antimicrobial resistance is one of the major problems in current practical medicine. The
spread of genes coding for resistance determinants among bacteria challenges the use of …

Metallo-β-lactamases: structure, function, epidemiology, treatment options, and the development pipeline

SE Boyd, DM Livermore, DC Hooper… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Modern medicine is threatened by the global rise of antibiotic resistance, especially among
Gram-negative bacteria. Metallo-β-lactamase (MBL) enzymes are a particular concern and …

[HTML][HTML] Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria

Y Liu, Z Tong, J Shi, R Li, M Upton, Z Wang - Theranostics, 2021 - ncbi.nlm.nih.gov
Antimicrobial resistance has been a global health challenge that threatens our ability to
control and treat life-threatening bacterial infections. Despite ongoing efforts to identify new …

Antibiotic adjuvants: a versatile approach to combat antibiotic resistance

G Dhanda, Y Acharya, J Haldar - ACS omega, 2023 - ACS Publications
The problem of antibiotic resistance is on the rise, with multidrug-resistant strains emerging
even to the last resort antibiotics. The drug discovery process is often stalled by stringent cut …

Current status and recent research achievements in SiC/SiC composites

Y Katoh, LL Snead, CH Henager Jr, T Nozawa… - Journal of Nuclear …, 2014 - Elsevier
The silicon carbide fiber-reinforced silicon carbide matrix (SiC/SiC) composite system for
fusion applications has seen a continual evolution from development a fundamental …

Ten years with New Delhi metallo-β-lactamase-1 (NDM-1): from structural insights to inhibitor design

P Linciano, L Cendron, E Gianquinto… - ACS infectious …, 2018 - ACS Publications
The worldwide emergence of New Delhi metallo-β-lactamase-1 (NDM-1) as a
carbapenemase able to hydrolyze nearly all available β-lactam antibiotics has characterized …

β-lactam/β-lactamase inhibitor combinations: an update

KHME Tehrani, NI Martin - Medchemcomm, 2018 - pubs.rsc.org
Antibiotic resistance caused by β-lactamase production continues to present a growing
challenge to the efficacy of β-lactams and their role as the most important class of clinically …

Metallo-ß-lactamases: a review

P Behzadi, HA García-Perdomo, TM Karpiński… - Molecular Biology …, 2020 - Springer
Microbial pathogens including Enterobacteriaceae family members bear different antibiotic
resistance genes comprising Extended-Spectrum-ß-Lactamases (ESBLs) and Metallo-ß …

The continuing challenge of metallo-β-lactamase inhibition: mechanism matters

LC Ju, Z Cheng, W Fast, RA Bonomo… - Trends in …, 2018 - cell.com
Metallo-β-lactamases (MBLs) are a significant clinical problem because they hydrolyze and
inactivate nearly all β-lactam-containing antibiotics. These 'lifesaving drugs' constitute> 50 …

Metallo-β-lactamase inhibitors inspired on snapshots from the catalytic mechanism

AR Palacios, MA Rossi, GS Mahler, AJ Vila - Biomolecules, 2020 - mdpi.com
β-Lactam antibiotics are the most widely prescribed antibacterial drugs due to their low
toxicity and broad spectrum. Their action is counteracted by different resistance mechanisms …